Curis
CRIS
#10205
Rank
NZ$29.47 M
Marketcap
NZ$2.28
Share price
-0.75%
Change (1 day)
-67.74%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -NZ$56.22 Million

According to Curis's latest financial reports the company's current earnings are NZ$11.65 Million. In 2024 the company made an earning of -NZ$73.88 Million, an increase over its 2023 earnings that were of -NZ$78.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$56.22 Million-23.9%
2024 -NZ$73.88 Million-5.77%
2023 -NZ$78.4 Million-13.1%
2022 -NZ$90.22 Million27.52%
2021 -NZ$70.75 Million65.09%
2020 -NZ$42.86 Million-9.1%
2019 -NZ$47.15 Million-4.73%
2018 -NZ$49.48 Million-41.95%
2017 -NZ$85.23 Million-14.37%
2016 -NZ$99.54 Million3.55%
2015 -NZ$96.12 Million271.52%
2014 -NZ$25.88 Million76.64%
2013 -NZ$14.65 Million
2011 -NZ$12.44 Million27.76%
2010 -NZ$9.74 Million-43.87%
2009 -NZ$17.35 Million-23.44%
2008 -NZ$22.66 Million56.66%
2007 -NZ$14.47 Million-16.71%
2006 -NZ$17.37 Million-36.92%
2005 -NZ$27.53 Million156.25%
2004 -NZ$10.75 Million-37.24%
2003 -NZ$17.12 Million-93.34%
2002 -NZ$0.26 Billion86.79%
2001 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exelixis
EXEL
NZ$1.50 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.46 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.87 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$42.7 Million-24.06%๐Ÿ‡บ๐Ÿ‡ธ USA